Recurrences in Sudden Sensorineural Hearing Loss: A Long-Term Observational Study

Am J Audiol. 2020 Mar 5;29(1):18-22. doi: 10.1044/2019_AJA-19-00061. Epub 2020 Jan 15.

Abstract

Purpose Long-term outcomes of sudden sensorineural hearing loss (SSNHL) are poorly studied. The recurrence rate is heterogeneous, and the prognosis of relapses is uncertain. The aim of this retrospective study was to evaluate the recurrence rate of SSNHL and to analyze the correlation with clinical and audiometric characteristics. Method Seventy-three patients with idiopatic SSNHL were evaluated. Clinical and audiometric features were recorded. Seventy patients (95.8%) had at least a 2-year follow-up, whereas 50 (68.4%) had a 5-year follow-up. Results Two- and 5-year recurrence rates were 5.60% and 10.34%, respectively. Mean time lapse between 1st episode and recurrence was 29.33 ± 26.60 months. About 70% of patients had a partial recovery at recurrence. The same ear was affected in 42.8% of patients, the contralateral ear was affected in 42.8% of patients, and recurrence was bilateral in 14.4% of cases. Recurrence correlated only with the presence of tinnitus during follow-up. However, the small number of participants with recurrence represented a limiting factor of our study. Conclusions Recurrences of SSNHL are rare events that can involve ipsilateral or contralateral ear. Further studies are necessary to identify predictors of recurrence.

Publication types

  • Observational Study

MeSH terms

  • Administration, Intravenous
  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Audiometry, Pure-Tone
  • Betamethasone / therapeutic use
  • Child
  • Diuretics, Osmotic / therapeutic use*
  • Female
  • Glucocorticoids / therapeutic use*
  • Hearing Loss, Sensorineural / physiopathology
  • Hearing Loss, Sensorineural / therapy*
  • Hearing Loss, Sudden / physiopathology
  • Hearing Loss, Sudden / therapy*
  • Humans
  • Hyperbaric Oxygenation*
  • Injection, Intratympanic
  • Longitudinal Studies
  • Male
  • Mannitol / therapeutic use
  • Middle Aged
  • Recovery of Function*
  • Recurrence
  • Retreatment
  • Time Factors
  • Young Adult

Substances

  • Diuretics, Osmotic
  • Glucocorticoids
  • Mannitol
  • Betamethasone